
Closing a Diagnostic Gap for Chronic Diarrhea
Answers From the Lab
Published September 17, 2026
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss seasonal vaccination planning and survey findings on laboratory industry growth. Later, Leslie Donato, Ph.D., a clinical chemist at Mayo Clinic, shares how an innovative testing panel is improving the diagnosis of bile acid malabsorption.
- Survey highlights laboratory growth strategies (00:29): Discover where laboratory leaders are investing, the challenges shaping the industry, and the strategies organizations are adopting to achieve sustainable growth.
- Seasonal viruses and vaccination planning (05:29): Discover how to learn more about vaccination options for viruses that typically surge during the fall and winter.
- Diagnostics for chronic diarrhea (07:43): Hear how a novel test is improving diagnosis and advancing understanding of bile acid malabsorption.
Note: Information in this post was accurate at the time of its posting.
Resources
Learn more Survey reveals four strategies for laboratory growth
Learn more Vaccine and immunization guidance from Mayo Clinic
Learn more Testing Options for Patients with Chronic Diarrhea: A Focus on Bile Acid Malabsorption Webinar
Learn more Bile acid malabsorption: A patient-centered approach to diagnose a common cause of chronic diarrhea
Learn more The right testing for an underrecognized cause of chronic diarrhea
Connect with Us
- Is there a question or topic you’d like us to explore in a future episode? Email us at mayocliniclabs@mayo.edu.
- Learn more about our hosts and guests and connect with them on social media.






